Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
69.93
-2.84 (-3.90%)
At close: Jan 23, 2026, 4:00 PM EST
70.00
+0.07 (0.10%)
After-hours: Jan 23, 2026, 7:45 PM EST
Kymera Therapeutics Employees
Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.
Employees
188
Change (1Y)
1
Growth (1Y)
0.53%
Revenue / Employee
$232,633
Profits / Employee
-$1,569,798
Market Cap
5.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 188 | 1 | 0.53% |
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 939 |
| Crinetics Pharmaceuticals | 437 |
| Vaxcyte | 414 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 362 |
| Mirum Pharmaceuticals | 322 |
| Cogent Biosciences | 205 |
| Apogee Therapeutics | 196 |
KYMR News
- 10 days ago - Kymera Therapeutics, Inc. (KYMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 11 days ago - Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewsWire
- 6 weeks ago - Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - Kymera Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 6 weeks ago - This Drugmaker's Stock Is Soaring Over 40% Monday - Investopedia
- 6 weeks ago - Kymera Therapeutics, Inc. (KYMR) Discusses KT-621 BroADen Phase 1b Results in Atopic Dermatitis Transcript - Seeking Alpha
- 6 weeks ago - Kymera's KT-621 Shines: Phase 1b Data Boosts Momentum - Seeking Alpha
- 6 weeks ago - Kymera Therapeutics Stock Soars 30%. Why Investors Are Excited About Its Anti-Inflammatory Drug. - Barrons